FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 4 filers reported holding FATE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $164 | +811.1% | 77,199 | +1962.5% | 0.01% | +600.0% |
| Q2 2023 | $18 | -14.3% | 3,743 | -0.6% | 0.00% | 0.0% |
| Q1 2023 | $21 | -44.7% | 3,764 | -0.3% | 0.00% | -50.0% |
| Q4 2022 | $38 | -100.0% | 3,777 | -16.8% | 0.00% | -50.0% |
| Q3 2022 | $102,000 | -28.2% | 4,542 | -20.8% | 0.00% | 0.0% |
| Q2 2022 | $142,000 | -36.0% | 5,732 | +0.2% | 0.00% | -20.0% |
| Q1 2022 | $222,000 | -42.2% | 5,723 | -12.9% | 0.01% | -37.5% |
| Q4 2021 | $384,000 | -0.8% | 6,571 | +0.6% | 0.01% | -11.1% |
| Q3 2021 | $387,000 | -34.6% | 6,535 | -4.2% | 0.01% | -18.2% |
| Q2 2021 | $592,000 | – | 6,825 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 716,392 | $11,126,000 | 12.18% |
| Polaris Venture Management Co. V, L.L.C. | 1,139,783 | $17,701,000 | 10.06% |
| Grosvenor Holdings, L.L.C. | 2,285,714 | $35,497,000 | 6.41% |
| Redmile Group, LLC | 11,216,809 | $174,197,000 | 5.83% |
| Casdin Capital, LLC | 2,550,000 | $39,601,500,000 | 4.10% |
| DAFNA Capital Management LLC | 470,000 | $7,299,000 | 2.74% |
| Ghost Tree Capital, LLC | 350,000 | $5,436,000 | 1.38% |
| Artal Group S.A. | 2,000,000 | $31,060,000 | 1.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,952,897 | $30,328,000 | 1.24% |
| Copernicus Capital Management, LLC | 75,000 | $1,165,000 | 1.08% |